trending Market Intelligence /marketintelligence/en/news-insights/trending/hmvxsvudrtumpuekd73yug2 content esgSubNav
In This List

Chembio Diagnostics appoints director

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Chembio Diagnostics appoints director

Chembio Diagnostics Inc. appointed John Potthoff to its board.

Potthoff is the CEO of Elligo Health Research Inc., a clinical research company in Austin, Texas.

Medford, N.Y.-based Chembio Diagnostics develops point-of-care diagnostic tests that are used to detect or monitor diseases.